Vunakizumab (Anti-CTLA-8 / IL-17a)
A2866
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameVunakizumab (Anti-CTLA-8 / IL-17a)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionVunakizumab (Anti-CTLA-8 / IL-17a) is a recombinant human IgGkappa monoclonal antibody that targets interleukin-17A (IL-17A) and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis. MW: 146.28.
- Storage Instruction-20°C
- UNSPSC12352203